CRSP vs IVZ · rev $11.6M vs rev $3.57B
Crispr Therapeutics AG (CRSP) versus Invesco Plc (IVZ) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
CRSP currently screens at market cap $5.42B. IVZ currently screens at market cap $12.76B.
Not investment advice. Open the CRSP and IVZ stock pages for the full models.
Not investment advice.